by Bruce Waldon | Mar 4, 2026 | FDA Approvals, Med-Devices, New devices, Product-Innovation, US-FDA
Medical Device Innovation Optune Pax treats pancreatic cancer with TTFields therapy Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR...
by Bruce Waldon | Mar 4, 2026 | Analysis, Device Warning Letters, FDA Enforcement, Industry Information, Industry News, Labeling, Med-Devices, Medical Device Labeling, Reg_Information, Regulatory_Info, US-FDA
MDP Regulatory Insight When apparel becomes a medical device Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact Lessons from FDA’s Breast Binder Warning...
by Bruce Waldon | Mar 4, 2026 | Compounding Labs, Drug Warning Letters, Industry Information, Industry News, Pharmaceutical Labeling, Pharmaceuticals, Telehealth, US-FDA
MDP Regulatory Insight FDA warns about compounded GLP-1 marketing claims Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Issues 30 Warning Letters to...
by Bruce Waldon | Dec 18, 2025 | Consumer Information, Consumer Safety, FDA Policy, FDA Public Information, Hormones, Industry Information, Industry News, Pharmaceuticals, Product Safety, Products_Drugs, US-FDA
Sudden Regulatory Shift FDA testosterone panel recommendations spark concern Home Request Info QMSR Central QMSR FAQs ISO 13485 Transition Impact Integration Definitions FDA and ISO 13485 ISO 9000 Small Manufacturers Concerns Over Sudden Regulatory Shift The FDA’s...
by Bruce Waldon | Dec 18, 2025 | Alerts-Pharma, Analysis, Consumer Information, Consumer Safety, Editorial, FDA Policy, FDA Regulations, Hormones, Industry Information, Industry News, Product Safety, Products_Drugs, Regulatory_Info
Testosterone Regulation Takes a Sharp Turn Why FDA’s December panel raises red flags Home Request Info QMSR Central QMSR FAQs ISO 13485 Transition Impact Integration Definitions FDA and ISO 13485 ISO 9000 Small Manufacturers Why FDA’s December Panel Raises Red Flags...
by Bruce Waldon | Dec 18, 2025 | Consumer Information, Editorial, FDA Regulations, Industry News
A Decade of Drift How testosterone regulation reached a crossroads Home Request Info QMSR Central QMSR FAQs ISO 13485 Transition Impact Integration Definitions FDA and ISO 13485 ISO 9000 Small Manufacturers How U.S. Testosterone Regulation Reached a Crossroads The...
